AI Article Synopsis
- A male infant was born with severe anemia due to foeto-maternal hemorrhage and was later diagnosed with a liver tumor that had spread to his lungs.
- The infant passed away before any treatment could be initiated, and a postmortem examination confirmed the presence of choriocarcinoma.
- The mother was subsequently diagnosed with the same cancer, which had also metastasized to her lungs, but she has since been successfully treated.
Article Abstract
A male infant, born following an uncomplicated pregnancy, was severely anaemic at birth following significant foeto-maternal haemorrhage. At three weeks of age a tumour was found in the liver with evidence of metastatic disease in the lungs. The infant died before treatment could be started. Postmortem revealed choriocarcinoma which led to subsequent diagnosis in the mother who also had pulmonary metastases. The mother has been successfully treated. The case is described in detail and followed by a discussion and a literature review of reported cases of simultaneous choriocarcinoma in infant and mother.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mpo.2950250611 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Choriocarcinoma in neonates and infants: A severe but curable disease.
Pediatr Blood Cancer
August 2024
SIREDO Oncology Centre (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France.
Article Synopsis
- Choriocarcinoma in neonates and infants (N-CC) is a rare but aggressive cancer often linked with maternal disease, with a median patient age of 6 weeks.
- A study analyzing eight cases revealed that all tumors were diffuse, and most patients underwent a platinum-based treatment regimen, with some requiring surgery for residual tumors.
- Despite a poor overall outcome, including half of the patients dying from the disease, four patients achieved complete remission, highlighting the potential for successful treatment through multimodal therapy.
The TGF-β/UCHL5/Smad2 Axis Contributes to the Pathogenesis of Placenta Accreta.
Int J Mol Sci
September 2023
Department of Obstetrics and Gynecology, Teikyo University School of Medicine, Tokyo 173-8605, Japan.
Placenta accreta is a high-risk condition causing obstetric crisis and hemorrhage; however, its pathogenesis remains unknown. We aimed to identify the factors contributing to trophoblast invasiveness and angiogenic potential, which in turn drive the pathogenesis of placenta accreta. We focused on the transforming growth factor (TGF)-β1-Smad pathway and investigated the intrinsic relationship between the time- and dose-dependent inhibition of the ubiquitinating enzyme UCHL5 using bAP15, a deubiquitinase inhibitor, after TGF-β1 stimulation and the invasive and angiogenic potential of two cell lines, gestational choriocarcinoma cell line JEG-3 and trophoblast cell line HTR-8/SVneo.
View Article and Find Full Text PDFGestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022).
Geburtshilfe Frauenheilkd
March 2023
Frauenklinik des Universitätsklinikums Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen/Europäische Metropolregion Nürnberg (CCC ER-EMN), Erlangen, Germany.
The aim was to develop and update a guideline which would improve the quality of care offered to women with gestational and non-gestational trophoblastic disease, a group of diseases characterized by their rarity and biological heterogeneity. In accordance with the method used to compile S2k-guidelines, the guideline authors carried out a search of the literature (MEDLINE) for the period 1/2020 to 12/2021 and evaluated the recent literature. No key questions were formulated.
View Article and Find Full Text PDFEvaluation of the Estrogenic Action Potential of Royal Jelly by Genomic Signaling Pathway in Vitro and in Vivo.
Biol Pharm Bull
October 2022
Laboratory of Hygienic Chemistry and Molecular Toxicology, Gifu Pharmaceutical University.
Royal jelly (RJ) has beneficial effects on human health, and some of these effects are reported to be the result of its estrogenic activity; however, chemicals with estrogenic activities may disrupt physiological estrogen signaling leading to adverse effects on human health. Thus, clarification of the mode of action of RJ is needed. Here, we investigated whether the estrogen-like actions of RJ are induced via estrogen receptors (ERs)-mediated genomic actions by using an in vitro reporter assay in human choriocarcinoma JEG3 cells and an estrogen-responsive reporter (E-Rep) mouse line that can be used to sensitively detect transactivation of ERs in multiple organs simultaneously.
View Article and Find Full Text PDFSimultaneous Occurrence of Choriocarcinoma in an Infant and Mother.
Int J Environ Res Public Health
February 2021
Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, 60-572 Poznań, Poland.
Infantile choriocarcinoma is an extremely rare disease. We present a case study of a 1-month-old male with choriocarcinoma diagnosed simultaneously with his mother. On admission to hospital, the disease was very advanced and massive progression and multi-organ failure caused the death of the patient despite the implemented treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!